Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Cycloastragenol upregulates SIRT1 expression, attenuates apoptosis and suppresses neuroinflammation after brain ischemia

Abstract

Cycloastragenol (CAG) is the active form of astragaloside IV isolated from Astragalus Radix, which displays multiple pharmacological effects. Silent information regulator 1 (SIRT1), a class III histone deacetylase, has been shown to play an important role in neuroprotection against cerebral ischemia. In this study, we investigated whether CAG protected against ischemic brain injury and, if so, whether the beneficial effects were associated with the regulation of SIRT1 in the ischemic brain. Mice were subjected to 45 min of middle cerebral artery occlusion (MCAO) followed by reperfusion. CAG (5, 10, 20 mg/kg) was injected intraperitoneally at the onset of reperfusion, 12 h later and then twice daily for up to three days. CAG dose-dependently reduced brain infarct volume, significantly ameliorated functional deficits, and prevented neuronal cell loss in MCAO mice. Meanwhile, CAG significantly reduced matrix metalloproteinase-9 activity, prevented tight junction degradation and subsequently ameliorated blood-brain barrier disruption. Moreover, CAG significantly upregulated SIRT1 expression in the ischemic brain but did not directly activate its enzymatic activity. Concomitant with SIRT1 upregulation, CAG reduced p53 acetylation and the ratio of Bax to Bcl-2 in the ischemic brain. CAG also inhibited NF-κB p65 nuclear translocation. As a result, CAG suppressed the mRNA expression of pro-inflammatory cytokines, including TNF-α and IL-1β, and inhibited the activation of microglia and astrocytes in the ischemic brain. Our findings suggest that CAG is neuroprotective against ischemic brain injury in mice and that its beneficial effect may involve SIRT1 upregulation and the inhibition of apoptosis and neuroinflammation in the ischemic brain.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

References

  1. 1.

    Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135:759–71.

    Article  Google Scholar 

  2. 2.

    Bordone L, Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol. 2005;6:298–305.

    CAS  Article  Google Scholar 

  3. 3.

    Zhang F, Wang S, Gan L, Vosler PS, Gao Y, Zigmond MJ, et al. Protective effects and mechanisms of sirtuins in the nervous system. Prog Neurobiol. 2011;95:373–95.

    CAS  Article  Google Scholar 

  4. 4.

    Koronowski KB, Perez-Pinzon MA. Sirt1 in cerebral ischemia. Brain Circ. 2015;1:69–78.

    Article  Google Scholar 

  5. 5.

    Zhang JF, Zhang YL, Wu YC. The role of Sirt1 in ischemic stroke: pathogenesis and therapeutic strategies. Front Neurosci. 2018;12:833.

    Article  Google Scholar 

  6. 6.

    Hernandez-Jimenez M, Hurtado O, Cuartero MI, Ballesteros I, Moraga A, Pradillo JM, et al. Silent information regulator 1 protects the brain against cerebral ischemic damage. Stroke. 2013;44:2333–7.

    CAS  Article  Google Scholar 

  7. 7.

    Hattori Y, Okamoto Y, Nagatsuka K, Takahashi R, Kalaria RN, Kinoshita M, et al. SIRT1 attenuates severe ischemic damage by preserving cerebral blood flow. Neuroreport. 2015;26:113–7.

    CAS  Article  Google Scholar 

  8. 8.

    Raval AP, Dave KR, Perez-Pinzon MA. Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab. 2006;26:1141–7.

    CAS  Article  Google Scholar 

  9. 9.

    Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience. 2009;159:993–1002.

    CAS  Article  Google Scholar 

  10. 10.

    Ren S, Zhang H, Mu Y, Sun M, Liu P. Pharmacological effects of Astragaloside IV: a literature review. J Tradit Chin Med. 2013;33:413–6.

    Article  Google Scholar 

  11. 11.

    Zhou RN, Song YL, Ruan JQ, Wang YT, Yan R. Pharmacokinetic evidence on the contribution of intestinal bacterial conversion to beneficial effects of astragaloside IV, a marker compound of astragali radix, in traditional oral use of the herb. Drug Metab Pharmacokinet. 2012;27:586–97.

    CAS  Article  Google Scholar 

  12. 12.

    Zhao Y, Li Q, Zhao W, Li J, Sun Y, Liu K, et al. Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium. J Ethnopharmacol. 2015;169:210–8.

    CAS  Article  Google Scholar 

  13. 13.

    Ma PK, Wei BH, Cao YL, Miao Q, Chen N, Guo CE, et al. Pharmacokinetics, metabolism, and excretion of cycloastragenol, a potent telomerase activator in rats. Xenobiotica. 2017;47:526–37.

    CAS  Article  Google Scholar 

  14. 14.

    Gu M, Zhang S, Zhao Y, Huang J, Wang Y, Li Y, et al. Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling. Pharmacol Res. 2017;121:22–32.

    CAS  Article  Google Scholar 

  15. 15.

    Wang Z, Tsai LK, Munasinghe J, Leng Y, Fessler EB, Chibane F, et al. Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke. Stroke. 2012;43:2430–6.

    CAS  Article  Google Scholar 

  16. 16.

    Dou B, Zhou W, Li S, Wang L, Wu X, Li Y, et al. Buyang Huanwu decoction attenuates infiltration of natural killer cells and protects against ischemic brain injury. Cell Physiol Biochem. 2018;50:1286–300.

    CAS  Article  Google Scholar 

  17. 17.

    Wang Z, Leng Y, Tsai LK, Leeds P, Chuang DM. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab. 2011;31:52–7.

    Article  Google Scholar 

  18. 18.

    Wu J, Zhang D, Chen L, Li J, Wang J, Ning C, et al. Discovery and mechanism study of SIRT1 activators that promote the deacetylation of fluorophore-labeled substrate. J Med Chem. 2013;56:761–80.

    CAS  Article  Google Scholar 

  19. 19.

    Horio Y, Hayashi T, Kuno A, Kunimoto R. Cellular and molecular effects of sirtuins in health and disease. Clin Sci (Lond). 2011;121:191–203.

    CAS  Article  Google Scholar 

  20. 20.

    Ramadori G, Lee CE, Bookout AL, Lee S, Williams KW, Anderson J, et al. Brain SIRT1: anatomical distribution and regulation by energy availability. J Neurosci. 2008;28:9989–96.

    CAS  Article  Google Scholar 

  21. 21.

    Sirotkin AV, Dekanova P, Harrath AH, Alwasel SH, Vasicek D. Interrelationships between sirtuin 1 and transcription factors p53 and NF-kappaB (p50/p65) in the control of ovarian cell apoptosis and proliferation. Cell Tissue Res. 2014;358:627–32.

    CAS  Article  Google Scholar 

  22. 22.

    Liu TF, McCall CE. Deacetylation by SIRT1 Reprograms inflammation and cancer. Genes Cancer. 2013;4:135–47.

    CAS  Article  Google Scholar 

  23. 23.

    Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001;107:149–59.

    CAS  Article  Google Scholar 

  24. 24.

    Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004;23:2369–80.

    CAS  Article  Google Scholar 

  25. 25.

    Raz L, Zhang QG, Han D, Dong Y, De Sevilla L, Brann DW. Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen. PLoS One. 2011;6:e27039.

    CAS  Article  Google Scholar 

  26. 26.

    Lanzillotta A, Sarnico I, Ingrassia R, Boroni F, Branca C, Benarese M, et al. The acetylation of RelA in Lys310 dictates the NF-kappaB-dependent response in post-ischemic injury. Cell Death Dis. 2010;1:e96.

    CAS  Article  Google Scholar 

  27. 27.

    Pfister JA, Ma C, Morrison BE, D’Mello SR. Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS One. 2008;3:e4090.

    Article  Google Scholar 

  28. 28.

    Chaturvedi M, Kaczmarek L. Mmp-9 inhibition: a therapeutic strategy in ischemic stroke. Mol Neurobiol. 2014;49:563–73.

    CAS  Article  Google Scholar 

  29. 29.

    Stamatovic SM, Martinez-Revollar G, Hu A, Choi J, Keep RF, Andjelkovic AV. Decline in Sirtuin-1 expression and activity plays a critical role in blood-brain barrier permeability in aging. Neurobiol Dis. 2019;126:105–16.

    CAS  Article  Google Scholar 

  30. 30.

    Zhou XM, Zhang X, Zhang XS, Zhuang Z, Li W, Sun Q, et al. SIRT1 inhibition by sirtinol aggravates brain edema after experimental subarachnoid hemorrhage. J Neurosci Res. 2014;92:714–22.

    CAS  Article  Google Scholar 

  31. 31.

    Sun P, Bu F, Min JW, Munshi Y, Howe MD, Liu L, et al. Inhibition of calcium/calmodulin-dependent protein kinase kinase (CaMKK) exacerbates impairment of endothelial cell and blood-brain barrier after stroke. Eur J Neurosci. 2019;49:27–39.

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by the National Natural Science Foundation of China (81873029).

Author information

Affiliations

Authors

Contributions

ML and ZFW designed the study. ML, SCL, BKD, YXZ and HZH performed the experiments. ML, SCL, DXL, ZJK and ZFW wrote the manuscript.

Corresponding author

Correspondence to Zhi-fei Wang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Li, M., Li, Sc., Dou, Bk. et al. Cycloastragenol upregulates SIRT1 expression, attenuates apoptosis and suppresses neuroinflammation after brain ischemia. Acta Pharmacol Sin 41, 1025–1032 (2020). https://doi.org/10.1038/s41401-020-0386-6

Download citation

Keywords

  • cycloastragenol
  • SIRT1
  • apoptosis
  • neuroinflammation
  • cerebral ischemia

Further reading

Search

Quick links